Cite
Periago A, Campillo JA, Mrowiec A, et al. Circulating aberrant plasma cells allows risk stratification of patients with myeloma. Am J Hematol. 2016;91(9):E353-E355doi: 10.1002/ajh.24431.
Periago, A., Campillo, J. A., Mrowiec, A., Gimeno, L., Montes, N. R., Martínez-Sánchez, M. V., Cabañas-Perianes, V., García-Garay, C., Bolarin, J. M., Blasco-Mogorrón, A., Muro, M., Berenguer, M., Moraleda, J. M., García-Alonso, A. M., & Minguela, A. (2016). Circulating aberrant plasma cells allows risk stratification of patients with myeloma. American journal of hematology, 91(9), E353-E355. https://doi.org/10.1002/ajh.24431
Periago, Adela, et al. "Circulating aberrant plasma cells allows risk stratification of patients with myeloma." American journal of hematology vol. 91,9 (2016): E353-E355. doi: https://doi.org/10.1002/ajh.24431
Periago A, Campillo JA, Mrowiec A, Gimeno L, Montes NR, Martínez-Sánchez MV, Cabañas-Perianes V, García-Garay C, Bolarin JM, Blasco-Mogorrón A, Muro M, Berenguer M, Moraleda JM, García-Alonso AM, Minguela A. Circulating aberrant plasma cells allows risk stratification of patients with myeloma. Am J Hematol. 2016 Sep;91(9):E353-E355. doi: 10.1002/ajh.24431. Epub 2016 May 24. PMID: 27220360.
Copy
Download .nbib